← FDA Drug Approvals (Drugs@FDA)
AIMOVIG
BLA · Biologics License Application · Sponsor: AMGEN INC · Approved 2018-05-17
Drug application
- FDA Application #
BLA761077- Application type
- Biologics License Application
- Brand name
- AIMOVIG
- Generic name
- ERENUMAB-AOOE
- Active ingredients
- ERENUMAB-AOOE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- AMGEN INC
- Manufacturer
- Amgen Inc
- First approval
- 2018-05-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown